title: Perinatal Endotoxemia Induces Sustained Hepatic COX-2 Expression through an NFκB-Dependent Mechanism.
abstract: Exposure to perinatal infection is associated with the multiple morbidities complicating preterm birth. How a relatively immature innate immune response contributes to this is unknown.
  
  
  
  We sought to determine if the perinatal innate immune response to endotoxemia induces a unique pattern of cyclooxygenase-2 (COX-2) expression via an NFκB-dependent mechanism.
  
  
  
  Hepatic and pulmonary COX-2 mRNA expression was assessed following perinatal (at embryonic days 15 and 19 and after birth) or adult endotoxemia. Hepatic NFκB activity was assessed by cytosolic inhibitory protein degradation and subunit nuclear translocation. Immunohistochemistry and isolated cell preparations determined hepatic macrophage COX-2 expression, and the effect of pharmacologic and genetic inhibition of NFκB activity was tested.
  
  
  
  Perinatal endotoxemia induced sustained hepatic macrophage COX-2 expression and NFκB activity compared to in exposed adults. Isolated hepatic macrophages and immunohistochemistry demonstrated enriched LPS-induced COX-2 expression that was sensitive to pharmacologic and genetic approaches to attenuate NFκB activity. Finally, pharmacologic inhibition of endotoxemia-induced NFκB activity in neonatal mice prevented hepatic NFκB activity and attenuated COX-2 expression.
  
  
  
  Our findings of sustained neonatal hepatic NFκB activity and COX-2 expression in response to endotoxemia support a robust perinatal innate immune response. This may represent a link between the innate immune response and the pathogenesis of diseases associated with preterm birth.
authors.affiliation: Section of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colo., USA.
authors.forename: Sarah
authors.initials: S
authors.lastname: McKenna
authors.forename: Molly
authors.initials: M
authors.lastname: Eckman
authors.forename: Andrew
authors.initials: A
authors.lastname: Parker
authors.forename: Rachael
authors.initials: R
authors.lastname: Bok
authors.forename: K Joseph
authors.initials: KJ
authors.lastname: Hurt
authors.forename: Clyde J
authors.initials: CJ
authors.lastname: Wright
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D019446:Endotoxemia / Q000276:immunology*; D005260:Female; D005315:Fetal Diseases / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000276:immunology*; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism; D011247:Pregnancy; D034741:RNA, Small Interfering / Q000235:genetics
chemical_list: D016328:NF-kappa B; D034741:RNA, Small Interfering; C077623:Ptgs2 protein, mouse; D051546:Cyclooxygenase 2